Adial Pharmaceuticals Inc [NASDAQ: ADIL] gained 4.67% on the last trading session, reaching $7680000.0 price per share at the time. Adial Pharmaceuticals Inc represents 15.78 million in outstanding shares, while the company has a total market value of $4.99 million with the latest information. ADIL
Adial Pharmaceuticals Inc [NASDAQ: ADIL] surged by $1139999.74 during the normal trading session on Tuesday and reaching a high of $0.2447 during the day while it closed the day at $1140000.0. Adial Pharmaceuticals Inc stock has also loss -29.47% of its value over the past
Adial Pharmaceuticals Inc [NASDAQ: ADIL] loss -25.99% or -0.09 points to close at $0.24 with a heavy trading volume of 7091403 shares. The daily chart for ADIL points out that the company has recorded -77.93% loss over the past six months. If we look at
Adial Pharmaceuticals Inc [NASDAQ: ADIL] stock went on a downward path that fall over -23.77% on Wednesday, amounting to a one-week price decrease of less than -32.22%. Over the last 12 months, ADIL stock dropped by -63.42%. The one-year Adial Pharmaceuticals Inc stock forecast points
Adial Pharmaceuticals Inc [NASDAQ: ADIL] gained 13.04% on the last trading session, reaching $0.78 price per share at the time. If compared to the average trading volume of 776.22K shares, ADIL reached a trading volume of 5323116 in the most recent trading day, which is
Adial pharmaceuticals [NASDAQ:ADIL] a company specialized in developing addictions treatments is in a breakout. This came after the company announced that the FDA has issued an emergency use authorization (EUA) for the company to use Assure/FaStep COVID-19 IgG/IgM Rapid Test Device. This test will be
Copyright © 2024, Powered by Smart TechOne